Literature DB >> 25956834

Lifestyle Intervention in Gastroesophageal Reflux Disease.

Eivind Ness-Jensen1, Kristian Hveem2, Hashem El-Serag3, Jesper Lagergren4.   

Abstract

BACKGROUND & AIMS: Gastroesophageal reflux disease (GERD) affects up to 30% of adults in Western populations and is increasing in prevalence. GERD is associated with lifestyle factors, particularly obesity and tobacco smoking, which also threatens the patient's general health. GERD carries the risk of several adverse outcomes and there is widespread use of potent acid-inhibitors, which are associated with long-term adverse effects. The aim of this systematic review was to assess the role of lifestyle intervention in the treatment of GERD.
METHODS: Literature searches were performed in PubMed (from 1946), EMBASE (from 1980), and the Cochrane Library (no start date) to October 1, 2014. Meta-analyses, systematic reviews, randomized clinical trials (RCTs), and prospective observational studies were included.
RESULTS: Weight loss was followed by decreased time with esophageal acid exposure in 2 RCTs (from 5.6% to 3.7% and from 8.0% to 5.5%), and reduced reflux symptoms in prospective observational studies. Tobacco smoking cessation reduced reflux symptoms in normal-weight individuals in a large prospective cohort study (odds ratio, 5.67). In RCTs, late evening meals increased time with supine acid exposure compared with early meals (5.2% point change), and head-of-the-bed elevation decreased time with supine acid exposure compared with a flat position (from 21% to 15%).
CONCLUSIONS: Weight loss and tobacco smoking cessation should be recommended to GERD patients who are obese and smoke, respectively. Avoiding late evening meals and head-of-the-bed elevation is effective in nocturnal GERD.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acid Regurgitation; GERD; Heartburn; Therapy; Treatment

Mesh:

Year:  2015        PMID: 25956834      PMCID: PMC4636482          DOI: 10.1016/j.cgh.2015.04.176

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  52 in total

1.  Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease?

Authors:  L Tefera; M Fein; M P Ritter; C G Bremner; P F Crookes; J H Peters; J A Hagen; T R DeMeester
Journal:  Am Surg       Date:  1997-10       Impact factor: 0.688

Review 2.  Clinical esophageal pH recording: a technical review for practice guideline development.

Authors:  P J Kahrilas; E M Quigley
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

Review 3.  The esophagogastric junction.

Authors:  R K Mittal; D H Balaban
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

4.  Sleeping on a wedge diminishes exposure of the esophagus to refluxed acid.

Authors:  J W Hamilton; R J Boisen; D T Yamamoto; J L Wagner; M Reichelderfer
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

5.  The effect of cigarette smoking on salivation and esophageal acid clearance.

Authors:  P J Kahrilas; R R Gupta
Journal:  J Lab Clin Med       Date:  1989-10

6.  Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight.

Authors:  C A Fraser-Moodie; B Norton; C Gornall; S Magnago; A R Weale; G K Holmes
Journal:  Scand J Gastroenterol       Date:  1999-04       Impact factor: 2.423

7.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

Authors:  J Lagergren; R Bergström; A Lindgren; O Nyrén
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

8.  Gastroesophageal reflux in obese patients is not reduced by weight reduction.

Authors:  A Kjellin; S Ramel; S Rössner; K Thor
Journal:  Scand J Gastroenterol       Date:  1996-11       Impact factor: 2.423

9.  Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension.

Authors:  L M Mathus-Vliegen; G N Tytgat
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-07       Impact factor: 2.566

10.  Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux.

Authors:  M Nilsson; R Johnsen; W Ye; K Hveem; J Lagergren
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

View more
  48 in total

Review 1.  The Proton Pump Inhibitor Nonresponder: a Behavioral Approach to Improvement and Wellness.

Authors:  Megan E Riehl; Joan W Chen
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

2.  Approach to GERD.

Authors:  Val E Ginzburg
Journal:  Can Fam Physician       Date:  2017-08       Impact factor: 3.275

Review 3.  Can We Use Diet to Effectively Treat Esophageal Disease? A Review of the Current Literature.

Authors:  Carolyn Newberry; Kristle Lynch
Journal:  Curr Gastroenterol Rep       Date:  2017-08

Review 4.  GERD Management: The Case for Lifestyle in an Era of PPIs.

Authors:  Joelle Ayoub; Nicole D White
Journal:  Am J Lifestyle Med       Date:  2017-01-10

Review 5.  Gastroesophageal Reflux After Sleeve Gastrectomy.

Authors:  Francisco A Guzman-Pruneda; Stacy A Brethauer
Journal:  J Gastrointest Surg       Date:  2020-09-15       Impact factor: 3.452

Review 6.  The role of diet in the development and management of gastroesophageal reflux disease: why we feel the burn.

Authors:  Carolyn Newberry; Kristle Lynch
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

Review 7.  Presentation and Epidemiology of Gastroesophageal Reflux Disease.

Authors:  Joel E Richter; Joel H Rubenstein
Journal:  Gastroenterology       Date:  2017-08-03       Impact factor: 22.682

Review 8.  Endoluminal Therapy for Gastroesophageal Reflux Disease: In Between the Pill and the Knife?

Authors:  Tony S Brar; Peter V Draganov; Dennis Yang
Journal:  Dig Dis Sci       Date:  2016-10-28       Impact factor: 3.199

Review 9.  The Gluten-Free Diet: Use in Digestive Disease Management.

Authors:  Carolyn Newberry
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

Review 10.  Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin.

Authors:  Jing Li; Xiaoxin Luke Chen; Anisa Shaker; Tadayuki Oshima; Jing Shan; Hiroto Miwa; Cheng Feng; Jun Zhang
Journal:  Ann N Y Acad Sci       Date:  2016-07-21       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.